BioCryst Pharmaceuticals, Inc. (BCRX)

NASDAQ: BCRX · Real-Time Price · USD

6.79

-0.04 (-0.59%)

At close: Apr 7, 2025, 4:00 PM

6.92

+0.13 (1.91%)

Pre-market: Apr 8, 2025, 8:25 AM EDT

BioCryst Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Revenue	450.71	331.41	270.83	157.17	17.81	Upgrade
Revenue Growth (YoY)	36.00%	22.37%	72.31%	782.38%	-63.53%	Upgrade
Cost of Revenue	185.92	216.65	259.89	216.07	124.64	Upgrade
Gross Profit	264.79	114.76	10.94	-58.9	-106.83	Upgrade
Selling, General & Admin	266.07	213.54	159.37	118.82	62.9	Upgrade
Operating Expenses	266.07	213.54	159.37	118.82	62.9	Upgrade
Operating Income	-1.28	-98.78	-148.44	-177.72	-169.73	Upgrade
Interest Expense	-98.52	-108.24	-99.09	-59.29	-14.5	Upgrade
Interest & Investment Income	14.75	15.78	5.13	0.06	0.53	Upgrade
Currency Exchange Gain (Loss)	-0.64	-1.04	-1.98	-0.7	-0.97	Upgrade
EBT Excluding Unusual Items	-85.69	-192.28	-244.38	-237.65	-184.67	Upgrade
Merger & Restructuring Charges	-1.26	-3.38	-	-	-	Upgrade
Gain (Loss) on Sale of Investments	-	-	-	0	-	Upgrade
Asset Writedown	-	-1.55	-	-	-	Upgrade
Legal Settlements	-	-	-	-	3.87	Upgrade
Other Unusual Items	-	-29.02	-	55.84	-2.01	Upgrade
Pretax Income	-86.95	-226.23	-244.38	-181.81	-182.81	Upgrade
Income Tax Expense	1.93	0.31	2.73	2.25	-	Upgrade
Net Income	-88.88	-226.54	-247.12	-184.06	-182.81	Upgrade
Net Income to Common	-88.88	-226.54	-247.12	-184.06	-182.81	Upgrade
Shares Outstanding (Basic)	207	192	186	179	167	Upgrade
Shares Outstanding (Diluted)	207	192	186	179	167	Upgrade
Shares Change (YoY)	7.54%	3.38%	3.79%	7.08%	44.70%	Upgrade
EPS (Basic)	-0.43	-1.18	-1.33	-1.03	-1.09	Upgrade
EPS (Diluted)	-0.43	-1.18	-1.33	-1.03	-1.09	Upgrade
Free Cash Flow	-53.14	-97.31	-163.2	-144.54	-135.62	Upgrade
Free Cash Flow Per Share	-0.26	-0.51	-0.88	-0.81	-0.81	Upgrade
Gross Margin	58.75%	34.63%	4.04%	-37.48%	-	Upgrade
Operating Margin	-0.28%	-29.81%	-54.81%	-113.07%	-952.90%	Upgrade
Profit Margin	-19.72%	-68.36%	-91.25%	-117.11%	-1026.35%	Upgrade
Free Cash Flow Margin	-11.79%	-29.36%	-60.26%	-91.97%	-761.41%	Upgrade
EBITDA	1.73	-95.91	-146.18	-176.83	-168.98	Upgrade
EBITDA Margin	0.39%	-28.94%	-53.98%	-112.51%	-	Upgrade
D&A For EBITDA	3.01	2.87	2.25	0.89	0.75	Upgrade
EBIT	-1.28	-98.78	-148.44	-177.72	-169.73	Upgrade
EBIT Margin	-0.28%	-29.81%	-54.81%	-113.07%	-	Upgrade
Revenue as Reported	-	-	-	-	17.81	Upgrade
Advertising Expenses	13.57	14.4	14.89	5.71	6.57	Upgrade

Updated Feb 25, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q